WHO To Pilot ‘Biological Qualifier’ Scheme Despite Protests From Biosimilars Industry
Executive Summary
The World Health Organization has decided to pursue its “Biological Qualifier” scheme despite concerns that it may conflict with other traceability systems. Calls by the European biosimilars industry to put the scheme on ice appear to have fallen on deaf ears.
You may also be interested in...
Kox Named As IGBA Secretary General
Industry veteran Suzette Kox has been nominated as secretary general of the International Generic and Biosimilar medicines Association.
Generics Body Attacks WHO's 'Immature' Biological Qualifier Scheme
The World Health Organization's 'biological qualifier' scheme has its supporters and its detractors, with the former believing it will improve drug use and monitoring, and the latter thinking it at best superfluous and at worst a potential source of confusion and regulatory misalignment.
EU Adopts New Rules On UK-Wide Approvals For Novel Drugs
Having been passed by the European Parliament and now the Council of the EU, new legislation will clear up some of the issues raised by Brexit relating to trade in medicines between Great Britain and Northern Ireland.